Seoul, Seoul-t'ukpyolsi, South Korea The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Murex Partners, startups are often financed by KB Investment, Bass Investment, TL Asset Management. The meaningful sponsors for the fund in investment in the same round are Bass Investment, KB Investment, Dunamu & Partners. In the next rounds fund is usually obtained by Bass Investment, Shinhan Bank, DS Asset Management.
We also calculated 2 valuable employees in our database.
We can highlight the next thriving fund investment areas, such as Finance, Medical. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight ImpriMed, HonestFund, HonestFund. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The high activity for fund was in 2018. When the investment is from Murex Partners the average startup value is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 9588 Online Travel | Beijing, Beijing, China |
| Align Capital Partners | Dallas, Texas, United States |
| Bige Meike | Beijing, Beijing, China |
| Hutton Collins Partners | England, London, United Kingdom |
| Intelligent Beauty | Central Region, Malta, Valletta |
| JC6 | - |
| LG Capital | Pfaffikon, Switzerland, Zurich |
| Logo Ventures | Istanbul, Istanbul, Turkey |
| Moelis & Company | New York, New York, United States |
| MrPink VC | Delaware, Ohio, United States |
| NEST-TN | Tennessee, Tullahoma, United States |
| New Lab | New York, New York, United States |
| Qbic | England, London, United Kingdom |
| Shenzhen Qianhai HuizhiTongbao Investment Fund | - |
| Tandem Ventures | - |
| Village Ventures | Massachusetts, United States, Williamstown |
| Xinqi Investment | China, Shanghai |
| Zhuhai Hengqin Shuimu Zhuohua Management Consulting | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LIVEKLASS | 26 Sep 2024 | Kyonggi-do, Gyeonggi-do, South Korea | |||
Mycle | $4M | 23 Jul 2024 | Seongnam, Kyonggi-do, South Korea | ||
Glorang | $7M | 10 Jun 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Algocare | $13M | 14 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Redrob | $4M | 19 Dec 2023 | Noida, Uttar Pradesh, India | ||
Habit Factory | $17M | 28 Nov 2023 | Yongsan, Seoul-t'ukpyolsi, South Korea | ||
onestepmore(caredoc) | $14M | 15 Nov 2023 | South Korea, Gyeonggi-do, South Korea | ||
ImpriMed | $23M | 10 Nov 2023 | Palo Alto, California, United States | ||
Allganize | $4M | 06 Nov 2023 | Oakland, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LIVEKLASS | 26 Sep 2024 | Kyonggi-do, Gyeonggi-do, South Korea | |||
Mycle | $4M | 23 Jul 2024 | Seongnam, Kyonggi-do, South Korea | ||
Glorang | $7M | 10 Jun 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Algocare | $13M | 14 Mar 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Redrob | $4M | 19 Dec 2023 | Noida, Uttar Pradesh, India | ||
Habit Factory | $17M | 28 Nov 2023 | Yongsan, Seoul-t'ukpyolsi, South Korea | ||
onestepmore(caredoc) | $14M | 15 Nov 2023 | South Korea, Gyeonggi-do, South Korea | ||
ImpriMed | $23M | 10 Nov 2023 | Palo Alto, California, United States | ||
Allganize | $4M | 06 Nov 2023 | Oakland, California, United States |
